Legal Representation
Attorney
Thomas A. Polcyn
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 1, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 1, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Mar 5, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 5, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 28, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 12, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Nutraceutical supplement in powder, capsule, and liquid form, namely, creatine, creatine isolate, tri-creatine malate, creatine decanoate, creatine orotate, creatine AKG, creatine HMB, arginine, arginine alpha ketoglutarate, l-arginine Hcl, arginine KIC, arginine decanoate, beta-alanine, betaine, l-citrulline, l-norvaline, l-ornithine, caffeine, alpha lipoic acids, amino acids, branch chain amino acids, vitamins, minerals, carbohydrates, and proteins for building body mass
First Use Anywhere:
Dec 31, 2022
First Use in Commerce:
Dec 31, 2022
Classification
International Classes
005